Targeting the HIF-1α–BSG metabolic circuit reverses enzalutamide resistance in prostate cancer
Cellular Signalling
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Targeting the HIF-1α–BSG metabolic circuit reverses enzalutamide resistance in prostate cancer. // Cellular Signalling. – URL: https://www.sciencedirect.com/science/article/pii/S0898656826006078?dgcid=rss_sd_all
Targeting the HIF-1α–BSG metabolic circuit reverses enzalutamide resistance in prostate cancer. Cellular Signalling. https://www.sciencedirect.com/science/article/pii/S0898656826006078?dgcid=rss_sd_all
“Targeting the HIF-1α–BSG metabolic circuit reverses enzalutamide resistance in prostate cancer.” Cellular Signalling.
@article{article107239,
title = {Targeting the HIF-1α–BSG metabolic circuit reverses enzalutamide resistance in prostate cancer},
journal = {Cellular Signalling},
url = {https://www.sciencedirect.com/science/article/pii/S0898656826006078?dgcid=rss_sd_all}
}